Non-small Cell Lung Cancer Study US75 (Z-PACT)
This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer. This study will measure the effects of this combination on progression of lung cancer, cancer response to treatments, and development of cancer-related bone lesions.
Checked against the public recordLast updated Sep 13, 2017 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Prevention
- Study type
- Interventional
- Phase
- Phase 3
- Sponsor
- Novartis Pharmaceuticals
- Interventions being studied
- Drug: zoledronic acid; Drug: Taxotere; Drug: Carboplatin
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Male or Female patients at least of 18 years old * Patients with diagnosed non-small cell lung cancer that cannot be treated by surgery * Women must not be pregnant or attempting to become pregnant * Able and willing to sign informed consent Exclusion Criteria: * Patients with cancer that has spread to the bone * Patients with cancer that has spread to the brain who are receiving treatment * Patients with kidney disease * Patients treated with other investigational drugs
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Clinical Research ConsultantsHoover, Alabama
- Arizona Oncology Assoc.Tucson, Arizona
- NEA ClinicJonesboro, Arkansas
- Highlands Oncology GroupSpringdale, Arkansas
- NorthBay Cancer CenterFairfield, California
- UCLALos Angeles, California
- Clinical Trials and Research Associates, Inc.Montebello, California
- Med. Oncology Care AssociatesOrange, California
- Cancer Center of Santa BarbaraSanta Barbara, California
- Cancer Center of Colorado SpringsColorado Springs, Colorado
- Northern Hematology-OncologyThornton, Colorado
- Lynn Regional Cancer CenterBoca Raton, Florida
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 13, 2017. Always confirm current availability with the study team.